LATEST ARTICLES
Thermo Fisher to buy research contractor PPD in $17B deal
Cancer biotech Tango to go public through $350M SPAC deal
Sage, Biogen drug reduces tremors but side effects could limit potential
GSK stops studies testing closely watched cancer immunotherapy
Moderna watches for ‘waning immunity’ as new data show durable vaccine protection
Merck, in latest COVID-19 setback, scraps one drug and pins hopes on another
Lilly claims promising finding in failed study of COVID-19 drug
With new data, Merck could be first to bring immunotherapy to early kidney cancer
Biogen adds a late-stage prospect to its growing biosimilar business
Gilead wins full approval for drug acquired in Immunomedics deal
Home
CURRENT FEATURES
Editorial Archive
Volume 3 Issue 3
Volume 3 Issue 2
Volume 3 Issue 1
Volume 2 Issue 4
Volume 2 Issue 3
Volume 2 Issue 2
Volume 2 Issue 1
Volume 1 Issue 3
Volume 1 Issue 2
Volume 1 Issue 1
ARCHIVED ISSUES
Events
Company Profile
Sponsored Articles
news
Clinical Trials Advisor
Drug Industry Daily
Drug GMP Report
Manufacturing & Packaging
Discovery & Development
eBooks
Podcast
Search
Close
Home
CURRENT FEATURES
Editorial Archive
Volume 3 Issue 3
Volume 3 Issue 2
Volume 3 Issue 1
Volume 2 Issue 4
Volume 2 Issue 3
Volume 2 Issue 2
Volume 2 Issue 1
Volume 1 Issue 3
Volume 1 Issue 2
Volume 1 Issue 1
ARCHIVED ISSUES
Events
Company Profile
Sponsored Articles
news
Clinical Trials Advisor
Drug Industry Daily
Drug GMP Report
Manufacturing & Packaging
Discovery & Development
eBooks
Podcast
Current Edition
Sorry, we couldn't find any posts. Please try a different search.